GE Healthcare IPO this year ‘looks unlikely’ after Danaher deal, CEO Culp says – CNBC
GE Healthcare IPO this year ‘looks unlikely’ after Danaher deal, CEO Culp says CNBC GE to sell BioPharma business to Danaher for $21.4B Fox Business GE to Sell Its Biotech Business to Danaher for $21...
from WordPress https://ift.tt/2EysfS9
via IFTTT
from WordPress https://ift.tt/2EysfS9
via IFTTT
Post A Comment
No comments :